 | • レポートコード：GIR-203B16188 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 全身麻酔薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の全身麻酔薬の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の全身麻酔薬の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 全身麻酔薬市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・プロポフォール、エトミダート、ミダゾラム、セボフルラン、イソフルラン、その他 用途別セグメントは次のように区分されます。 ・静脈麻酔薬、吸入麻酔薬 世界の全身麻酔薬市場の主要な市場プレーヤーは以下のとおりです。 ・Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、全身麻酔薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な全身麻酔薬メーカーの企業概要、2019年～2021年までの全身麻酔薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な全身麻酔薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別全身麻酔薬の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの全身麻酔薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での全身麻酔薬市場予測を収録しています。 ・第12、13、14章では、全身麻酔薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プロポフォール、エトミダート、ミダゾラム、セボフルラン、イソフルラン、その他 ・用途別分析2016年-2026年：静脈麻酔薬、吸入麻酔薬 ・全身麻酔薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・全身麻酔薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・全身麻酔薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・全身麻酔薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・全身麻酔薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The General Anesthesia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global General Anesthesia Drugs size is estimated to be XX million in 2021 from USD 7502.1 million in 2020, with a change of XX% between 2020 and 2021. The global General Anesthesia Drugs market size is expected to grow at a CAGR of 2.6% for the next five years.
Market segmentation
General Anesthesia Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
Market segment by Application can be divided into
Intravenous Anesthetics
Inhalational Anesthetics
The key market players for global General Anesthesia Drugs market are listed below:
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe General Anesthesia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of General Anesthesia Drugs, with price, sales, revenue and global market share of General Anesthesia Drugs from 2019 to 2021.
Chapter 3, the General Anesthesia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the General Anesthesia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and General Anesthesia Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe General Anesthesia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 General Anesthesia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global General Anesthesia Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Propofol
1.2.3 Etomidate
1.2.4 Midazolam
1.2.5 Sevoflurane
1.2.6 Isoflurane
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global General Anesthesia Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Global General Anesthesia Drugs Market Size & Forecast
1.4.1 Global General Anesthesia Drugs Sales in Value (2016-2026))
1.4.2 Global General Anesthesia Drugs Sales in Volume (2016-2026)
1.4.3 Global General Anesthesia Drugs Price by Type (2016-2026) & (US$/L)
1.5 Global General Anesthesia Drugs Production Capacity Analysis
1.5.1 Global General Anesthesia Drugs Total Production Capacity (2016-2026)
1.5.2 Global General Anesthesia Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 General Anesthesia Drugs Market Drivers
1.6.2 General Anesthesia Drugs Market Restraints
1.6.3 General Anesthesia Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca General Anesthesia Drugs Product and Services
2.1.4 Astrazeneca General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Fresenius-Kabi
2.2.1 Fresenius-Kabi Details
2.2.2 Fresenius-Kabi Major Business
2.2.3 Fresenius-Kabi General Anesthesia Drugs Product and Services
2.2.4 Fresenius-Kabi General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie General Anesthesia Drugs Product and Services
2.3.4 AbbVie General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Baxter Healthcare
2.4.1 Baxter Healthcare Details
2.4.2 Baxter Healthcare Major Business
2.4.3 Baxter Healthcare General Anesthesia Drugs Product and Services
2.4.4 Baxter Healthcare General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 B.Braun
2.5.1 B.Braun Details
2.5.2 B.Braun Major Business
2.5.3 B.Braun General Anesthesia Drugs Product and Services
2.5.4 B.Braun General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Maruishi
2.6.1 Maruishi Details
2.6.2 Maruishi Major Business
2.6.3 Maruishi General Anesthesia Drugs Product and Services
2.6.4 Maruishi General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Piramal
2.7.1 Piramal Details
2.7.2 Piramal Major Business
2.7.3 Piramal General Anesthesia Drugs Product and Services
2.7.4 Piramal General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Hikma Pharmaceuticals
2.8.1 Hikma Pharmaceuticals Details
2.8.2 Hikma Pharmaceuticals Major Business
2.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
2.8.4 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan General Anesthesia Drugs Product and Services
2.9.4 Mylan General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Nhwa
2.10.1 Nhwa Details
2.10.2 Nhwa Major Business
2.10.3 Nhwa General Anesthesia Drugs Product and Services
2.10.4 Nhwa General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Hengrui
2.11.1 Hengrui Details
2.11.2 Hengrui Major Business
2.11.3 Hengrui General Anesthesia Drugs Product and Services
2.11.4 Hengrui General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Lunan
2.12.1 Lunan Details
2.12.2 Lunan Major Business
2.12.3 Lunan General Anesthesia Drugs Product and Services
2.12.4 Lunan General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 General Anesthesia Drugs Sales by Manufacturer
3.1 Global General Anesthesia Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global General Anesthesia Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in General Anesthesia Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 General Anesthesia Drugs Manufacturer Market Share
3.4.2 Top 6 General Anesthesia Drugs Manufacturer Market Share
3.5 Global General Anesthesia Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and General Anesthesia Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global General Anesthesia Drugs Market Size by Region
4.1.1 Global General Anesthesia Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global General Anesthesia Drugs Revenue by Region (2016-2026)
4.2 North America General Anesthesia Drugs Revenue (2016-2026)
4.3 Europe General Anesthesia Drugs Revenue (2016-2026)
4.4 Asia-Pacific General Anesthesia Drugs Revenue (2016-2026)
4.5 South America General Anesthesia Drugs Revenue (2016-2026)
4.6 Middle East and Africa General Anesthesia Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global General Anesthesia Drugs Sales in Volume by Type (2016-2026)
5.2 Global General Anesthesia Drugs Revenue by Type (2016-2026)
5.3 Global General Anesthesia Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global General Anesthesia Drugs Sales in Volume by Application (2016-2026)
6.2 Global General Anesthesia Drugs Revenue by Application (2016-2026)
6.3 Global General Anesthesia Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America General Anesthesia Drugs Sales by Type (2016-2026)
7.2 North America General Anesthesia Drugs Sales by Application (2016-2026)
7.3 North America General Anesthesia Drugs Market Size by Country
7.3.1 North America General Anesthesia Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America General Anesthesia Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe General Anesthesia Drugs Sales by Type (2016-2026)
8.2 Europe General Anesthesia Drugs Sales by Application (2016-2026)
8.3 Europe General Anesthesia Drugs Market Size by Country
8.3.1 Europe General Anesthesia Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe General Anesthesia Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific General Anesthesia Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific General Anesthesia Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific General Anesthesia Drugs Market Size by Region
9.3.1 Asia-Pacific General Anesthesia Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific General Anesthesia Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America General Anesthesia Drugs Sales by Type (2016-2026)
10.2 South America General Anesthesia Drugs Sales by Application (2016-2026)
10.3 South America General Anesthesia Drugs Market Size by Country
10.3.1 South America General Anesthesia Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America General Anesthesia Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa General Anesthesia Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa General Anesthesia Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa General Anesthesia Drugs Market Size by Country
11.3.1 Middle East & Africa General Anesthesia Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa General Anesthesia Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 General Anesthesia Drugs Typical Distributors
12.3 General Anesthesia Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global General Anesthesia Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global General Anesthesia Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 4. Astrazeneca Major Business
Table 5. Astrazeneca General Anesthesia Drugs Product and Services
Table 6. Astrazeneca General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 8. Fresenius-Kabi Major Business
Table 9. Fresenius-Kabi General Anesthesia Drugs Product and Services
Table 10. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AbbVie Basic Information, Manufacturing Base and Competitors
Table 12. AbbVie Major Business
Table 13. AbbVie General Anesthesia Drugs Product and Services
Table 14. AbbVie General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 16. Baxter Healthcare Major Business
Table 17. Baxter Healthcare General Anesthesia Drugs Product and Services
Table 18. Baxter Healthcare General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. B.Braun Basic Information, Manufacturing Base and Competitors
Table 20. B.Braun Major Business
Table 21. B.Braun General Anesthesia Drugs Product and Services
Table 22. B.Braun General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Maruishi Basic Information, Manufacturing Base and Competitors
Table 24. Maruishi Major Business
Table 25. Maruishi General Anesthesia Drugs Product and Services
Table 26. Maruishi General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Piramal Basic Information, Manufacturing Base and Competitors
Table 28. Piramal Major Business
Table 29. Piramal General Anesthesia Drugs Product and Services
Table 30. Piramal General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Hikma Pharmaceuticals Major Business
Table 33. Hikma Pharmaceuticals General Anesthesia Drugs Product and Services
Table 34. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Mylan Basic Information, Manufacturing Base and Competitors
Table 36. Mylan Major Business
Table 37. Mylan General Anesthesia Drugs Product and Services
Table 38. Mylan General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Nhwa Basic Information, Manufacturing Base and Competitors
Table 40. Nhwa Major Business
Table 41. Nhwa General Anesthesia Drugs Product and Services
Table 42. Nhwa General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hengrui Basic Information, Manufacturing Base and Competitors
Table 44. Hengrui Major Business
Table 45. Hengrui General Anesthesia Drugs Product and Services
Table 46. Hengrui General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Lunan Basic Information, Manufacturing Base and Competitors
Table 48. Lunan Major Business
Table 49. Lunan General Anesthesia Drugs Product and Services
Table 50. Lunan General Anesthesia Drugs Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global General Anesthesia Drugs Sales by Manufacturer (2019-2021e) & (K L)
Table 52. Global General Anesthesia Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in General Anesthesia Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global General Anesthesia Drugs Production Capacity by Company, (K L): 2020 VS 2021
Table 55. Head Office and General Anesthesia Drugs Production Site of Key Manufacturer
Table 56. General Anesthesia Drugs New Entrant and Capacity Expansion Plans
Table 57. General Anesthesia Drugs Mergers & Acquisitions in the Past Five Years
Table 58. Global General Anesthesia Drugs Sales by Region (2016-2021e) & (K L)
Table 59. Global General Anesthesia Drugs Sales by Region (2021-2026) & (K L)
Table 60. Global General Anesthesia Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global General Anesthesia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 62. Global General Anesthesia Drugs Sales by Type (2016-2021e) & (K L)
Table 63. Global General Anesthesia Drugs Sales by Type (2021-2026) & (K L)
Table 64. Global General Anesthesia Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global General Anesthesia Drugs Revenue by Type (2021-2026) & (USD Million)
Table 66. Global General Anesthesia Drugs Price by Type (2016-2021e) & (US$/L)
Table 67. Global General Anesthesia Drugs Price by Type (2021-2026) & (US$/L)
Table 68. Global General Anesthesia Drugs Sales by Application (2016-2021e) & (K L)
Table 69. Global General Anesthesia Drugs Sales by Application (2021-2026) & (K L)
Table 70. Global General Anesthesia Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global General Anesthesia Drugs Revenue by Application (2021-2026) & (USD Million)
Table 72. Global General Anesthesia Drugs Price by Application (2016-2021e) & (US$/L)
Table 73. Global General Anesthesia Drugs Price by Application (2021-2026) & (US$/L)
Table 74. North America General Anesthesia Drugs Sales by Country (2016-2021e) & (K L)
Table 75. North America General Anesthesia Drugs Sales by Country (2021-2026) & (K L)
Table 76. North America General Anesthesia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America General Anesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 78. North America General Anesthesia Drugs Sales by Type (2016-2021e) & (K L)
Table 79. North America General Anesthesia Drugs Sales by Type (2021-2026) & (K L)
Table 80. North America General Anesthesia Drugs Sales by Application (2016-2021e) & (K L)
Table 81. North America General Anesthesia Drugs Sales by Application (2021-2026) & (K L)
Table 82. Europe General Anesthesia Drugs Sales by Country (2016-2021e) & (K L)
Table 83. Europe General Anesthesia Drugs Sales by Country (2021-2026) & (K L)
Table 84. Europe General Anesthesia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe General Anesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe General Anesthesia Drugs Sales by Type (2016-2021e) & (K L)
Table 87. Europe General Anesthesia Drugs Sales by Type (2021-2026) & (K L)
Table 88. Europe General Anesthesia Drugs Sales by Application (2016-2021e) & (K L)
Table 89. Europe General Anesthesia Drugs Sales by Application (2021-2026) & (K L)
Table 90. Asia-Pacific General Anesthesia Drugs Sales by Region (2016-2021e) & (K L)
Table 91. Asia-Pacific General Anesthesia Drugs Sales by Region (2021-2026) & (K L)
Table 92. Asia-Pacific General Anesthesia Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific General Anesthesia Drugs Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific General Anesthesia Drugs Sales by Type (2016-2021e) & (K L)
Table 95. Asia-Pacific General Anesthesia Drugs Sales by Type (2021-2026) & (K L)
Table 96. Asia-Pacific General Anesthesia Drugs Sales by Application (2016-2021e) & (K L)
Table 97. Asia-Pacific General Anesthesia Drugs Sales by Application (2021-2026) & (K L)
Table 98. South America General Anesthesia Drugs Sales by Country (2016-2021e) & (K L)
Table 99. South America General Anesthesia Drugs Sales by Country (2021-2026) & (K L)
Table 100. South America General Anesthesia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America General Anesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 102. South America General Anesthesia Drugs Sales by Type (2016-2021e) & (K L)
Table 103. South America General Anesthesia Drugs Sales by Type (2021-2026) & (K L)
Table 104. South America General Anesthesia Drugs Sales by Application (2016-2021e) & (K L)
Table 105. South America General Anesthesia Drugs Sales by Application (2021-2026) & (K L)
Table 106. Middle East & Africa General Anesthesia Drugs Sales by Country (2016-2021e) & (K L)
Table 107. Middle East & Africa General Anesthesia Drugs Sales by Country (2021-2026) & (K L)
Table 108. Middle East & Africa General Anesthesia Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa General Anesthesia Drugs Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa General Anesthesia Drugs Sales by Type (2016-2021e) & (K L)
Table 111. Middle East & Africa General Anesthesia Drugs Sales by Type (2021-2026) & (K L)
Table 112. Middle East & Africa General Anesthesia Drugs Sales by Application (2016-2021e) & (K L)
Table 113. Middle East & Africa General Anesthesia Drugs Sales by Application (2021-2026) & (K L)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. General Anesthesia Drugs Typical Distributors
Table 117. General Anesthesia Drugs Typical Customers
List of Figures
Figure 1. General Anesthesia Drugs Picture
Figure 2. Global General Anesthesia Drugs Sales Market Share by Type in 2020
Figure 3. Propofol
Figure 4. Etomidate
Figure 5. Midazolam
Figure 6. Sevoflurane
Figure 7. Isoflurane
Figure 8. Others
Figure 9. Global General Anesthesia Drugs Sales Market Share by Application in 2020
Figure 10. Intravenous Anesthetics
Figure 11. Inhalational Anesthetics
Figure 12. Global General Anesthesia Drugs Market Size, (USD Million) & (K L): 2020 VS 2021 VS 2026
Figure 13. Global General Anesthesia Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global General Anesthesia Drugs Sales (2016-2026) & (K L)
Figure 15. Global General Anesthesia Drugs Price by Type (2016-2026) & (US$/L)
Figure 16. Global General Anesthesia Drugs Production Capacity (2016-2026) & (K L)
Figure 17. Global General Anesthesia Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. General Anesthesia Drugs Market Drivers
Figure 19. General Anesthesia Drugs Market Restraints
Figure 20. General Anesthesia Drugs Market Trends
Figure 21. Global General Anesthesia Drugs Sales Market Share by Manufacturer in 2020
Figure 22. Global General Anesthesia Drugs Revenue Market Share by Manufacturer in 2020
Figure 23. General Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 General Anesthesia Drugs Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 General Anesthesia Drugs Manufacturer (Revenue) Market Share in 2020
Figure 26. Global General Anesthesia Drugs Sales Market Share by Region (2016-2026)
Figure 27. Global General Anesthesia Drugs Revenue Market Share by Region (2016-2026)
Figure 28. North America General Anesthesia Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Europe General Anesthesia Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific General Anesthesia Drugs Revenue (2016-2026) & (USD Million)
Figure 31. South America General Anesthesia Drugs Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa General Anesthesia Drugs Revenue (2016-2026) & (USD Million)
Figure 33. Global General Anesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 34. Global General Anesthesia Drugs Revenue Market Share by Type (2016-2026)
Figure 35. Global General Anesthesia Drugs Price by Type (2016-2026) & (US$/L)
Figure 36. Global General Anesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 37. Global General Anesthesia Drugs Revenue Market Share by Application (2016-2026)
Figure 38. Global General Anesthesia Drugs Price by Application (2016-2026) & (US$/L)
Figure 39. North America General Anesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 40. North America General Anesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 41. North America General Anesthesia Drugs Sales Market Share by Country (2016-2026)
Figure 42. North America General Anesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 43. United States General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe General Anesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 47. Europe General Anesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 48. Europe General Anesthesia Drugs Sales Market Share by Country (2016-2026)
Figure 49. Europe General Anesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 50. Germany General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific General Anesthesia Drugs Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific General Anesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific General Anesthesia Drugs Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific General Anesthesia Drugs Revenue Market Share by Region (2016-2026)
Figure 59. China General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America General Anesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 66. South America General Anesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America General Anesthesia Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America General Anesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 69. Brazil General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa General Anesthesia Drugs Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa General Anesthesia Drugs Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa General Anesthesia Drugs Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa General Anesthesia Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa General Anesthesia Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
自動車用パワートレインのグローバル市場 2021年：企業別、地域別、種類・用途別 The Automotive Powertrain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…- 電気静水圧試験ポンプのグローバル市場 2021年：企業別、地域別、種類・用途別 The Electric Hydrostatic Test Pump market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 衛星センサーのグローバル市場 2021年：企業別、地域別、種類・用途別 The Satellite Sensor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- 剥離可能コーティング剤のグローバル市場 2021年：企業別、地域別、種類・用途別 The Removable Coatings market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 小型コンベヤチェーンのグローバル市場 2021年：企業別、地域別、種類・用途別 The Small Conveyor Chains market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…